Lyka Labs Limited (NSE:LYKALABS)
India · Delayed Price · Currency is INR 73.62
+1.44 (2.00%)
Aug 21, 2026, 3:14 PM IST
Lyka Labs Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,336 | 1,243 | 1,336 | 1,051 | 883.39 | 1,836 |
Other Revenue | 4.76 | 4.76 | 10.52 | 10.51 | 10.78 | 8.82 |
| 1,341 | 1,248 | 1,346 | 1,062 | 894.17 | 1,845 | |
Revenue Growth | -2.69% | -7.27% | 26.78% | 18.75% | -51.53% | 169.25% |
Cost of Revenue | 553.92 | 516.82 | 574.46 | 464.79 | 392.59 | 545.03 |
Gross Profit | 787.18 | 731.44 | 771.7 | 597.05 | 501.58 | 1,300 |
Selling, General & Admin | 488.93 | 464.51 | 385.55 | 295.71 | 204.02 | 194.64 |
Other Operating Expenses | 324.49 | 301.78 | 206.32 | 143.73 | 128.61 | 93.18 |
Operating Expenses | 896.79 | 850.68 | 659.35 | 567.46 | 474.1 | 461.32 |
Operating Income | -109.61 | -119.24 | 112.35 | 29.59 | 27.48 | 838.33 |
Interest Expense | -24.57 | -23.03 | -22.72 | -46.9 | -117.47 | -199.62 |
Interest & Investment Income | 16.89 | 16.89 | 4.63 | 8.62 | 21.54 | 13.41 |
Currency Exchange Gain (Loss) | 13.01 | 13.01 | 10.22 | 4.89 | 4.02 | 5.31 |
Other Non Operating Income (Expenses) | -7.34 | -5.21 | 6.99 | -1.43 | 6.67 | 0.23 |
EBT Excluding Unusual Items | -111.62 | -117.58 | 111.46 | -5.23 | -57.77 | 657.66 |
Impairment of Goodwill | -0.22 | -0.22 | -0.22 | - | - | - |
Asset Writedown | - | - | - | - | -0.78 | -24.11 |
Other Unusual Items | - | - | - | -4.11 | -73.16 | -41.08 |
Pretax Income | -111.83 | -117.8 | 111.25 | -9.34 | -131.71 | 592.47 |
Income Tax Expense | -17.98 | -13.44 | 31.92 | 16.87 | -0.19 | 208.04 |
Earnings From Continuing Operations | -93.85 | -104.36 | 79.33 | -26.21 | -131.53 | 384.43 |
Minority Interest in Earnings | 4.87 | 4.04 | 0.79 | 1.31 | -0.59 | 5.57 |
Net Income | -88.98 | -100.32 | 80.12 | -24.89 | -132.12 | 390 |
Preferred Dividends & Other Adjustments | - | - | 1.09 | 1.09 | 1.09 | 1.09 |
Net Income to Common | -88.98 | -100.32 | 79.03 | -25.98 | -133.2 | 388.91 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 35 | 36 | 36 | 33 | 29 | 29 |
Shares Outstanding (Diluted) | 35 | 36 | 36 | 33 | 29 | 29 |
Shares Change | -1.35% | 0.30% | 7.90% | 14.58% | 0.33% | - |
EPS (Basic) | -2.51 | -2.81 | 2.22 | -0.79 | -4.63 | 13.56 |
EPS (Diluted) | -2.51 | -2.81 | 2.22 | -0.79 | -4.63 | 13.56 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -58.88 | -137.55 | -74.58 | 7.67 | 717.33 |
Free Cash Flow Per Share | - | -1.65 | -3.87 | -2.26 | 0.27 | 25.00 |
Gross Margin | 58.70% | 58.60% | 57.33% | 56.23% | 56.09% | 70.45% |
Operating Margin | -8.17% | -9.55% | 8.35% | 2.79% | 3.07% | 45.45% |
Profit Margin | -6.64% | -8.04% | 5.87% | -2.45% | -14.90% | 21.08% |
Free Cash Flow Margin | - | -4.72% | -10.22% | -7.02% | 0.86% | 38.89% |
EBITDA | -45.06 | -58.65 | 157.11 | 157.61 | 168.95 | 1,012 |
EBITDA Margin | -3.36% | -4.70% | 11.67% | 14.84% | 18.89% | 54.85% |
D&A For EBITDA | 64.55 | 60.59 | 44.76 | 128.02 | 141.47 | 173.49 |
EBIT | -109.61 | -119.24 | 112.35 | 29.59 | 27.48 | 838.33 |
EBIT Margin | -8.17% | -9.55% | 8.35% | 2.79% | 3.07% | 45.45% |
Effective Tax Rate | - | - | 28.69% | - | - | 35.11% |
Revenue as Reported | 1,410 | 1,319 | 1,407 | 1,127 | 964.74 | 1,962 |
Advertising Expenses | - | 27.68 | 21.44 | 11.1 | 3.1 | 6.36 |